{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:42:40Z","timestamp":1792078960947,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jcin.2025.08.011","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:10:00Z","timestamp":1756282200000},"page":"2371-2388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Refining Bleeding Risk Stratification After TAVR"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4737-9882","authenticated-orcid":false,"given":"Shinnosuke","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonin","family":"Trimaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3477-208X","authenticated-orcid":false,"given":"Adrien","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Granier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinh Phi","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7034-1466","authenticated-orcid":false,"given":"Benjamin","family":"Marchandot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manh Cuong","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Kibler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Heyberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien Tse Sik","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Loizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Knellwolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorian","family":"Recht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baudouin","family":"Koenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Leddet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"De Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Jesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ohlmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Sattler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7295-3041","authenticated-orcid":false,"given":"Olivier","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jcin.2025.08.011_bib1","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.jcin.2025.08.011_bib2","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.jcin.2025.08.011_bib3","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.jacc.2014.08.052","article-title":"Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement","volume":"64","author":"Genereux","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"10.1016\/j.jcin.2025.08.011_bib4","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2013.03.029","article-title":"Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events","volume":"62","author":"Rodes-Cabau","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jcin.2025.08.011_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.acvd.2019.12.003","article-title":"The difficult balance between thrombosis and bleeding after transcatheter aortic valve replacement: a translational review","volume":"113","author":"Trimaille","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"issue":"7","key":"10.1016\/j.jcin.2025.08.011_bib6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jacc.2022.11.050","article-title":"Bleeding events after transcatheter aortic valve replacement: JACC state-of-the-art review","volume":"81","author":"Avvedimento","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.jcin.2025.08.011_bib7","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.jcin.2023.10.011","article-title":"Bleeding in patients undergoing transfemoral transcatheter aortic valve replacement: incidence, trends, clinical outcomes, and predictors","volume":"16","author":"van Nieuwkerk","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"31","key":"10.1016\/j.jcin.2025.08.011_bib8","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jcin.2025.08.011_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeab036","article-title":"Academic Research Consortium High Bleeding Risk Criteria associated with 2-year bleeding events and mortality after transcatheter aortic valve replacement discharge: a Japanese Multicentre Prospective OCEAN-TAVI registry study","volume":"1","author":"Mizutani","year":"2021","journal-title":"Eur Heart J Open"},{"issue":"6","key":"10.1016\/j.jcin.2025.08.011_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.4244\/EIJ-D-21-01048","article-title":"Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2","volume":"18","author":"Garot","year":"2022","journal-title":"EuroIntervention"},{"issue":"11","key":"10.1016\/j.jcin.2025.08.011_bib11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jcin.2021.01.007","article-title":"Assessment of the Academic Research Consortium for High Bleeding Risk criteria in patients undergoing TAVR","volume":"14","author":"Bor","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.jcin.2025.08.011_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4244\/EIJ-D-23-01020","article-title":"Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document","volume":"20","author":"Garot","year":"2024","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.jcin.2025.08.011_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.124.014800","article-title":"Validation of the Valve Academic Research Consortium high bleeding risk definition in patients undergoing TAVR","volume":"18","author":"Avvedimento","year":"2025","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.jcin.2025.08.011_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1505643","article-title":"Von Willebrand factor multimers during transcatheter aortic-valve replacement","volume":"375","author":"Van Belle","year":"2016","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.jcin.2025.08.011_bib15","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1056\/NEJMcibr1205363","article-title":"From clinical observation to mechanism\u2014Heyde\u2019s syndrome","volume":"367","author":"Loscalzo","year":"2012","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.jcin.2025.08.011_bib16","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.jacc.2018.08.2143","article-title":"Primary hemostatic disorders and late major bleeding after transcatheter aortic valve replacement","volume":"72","author":"Kibler","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jcin.2025.08.011_bib17","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1055\/a-2068-5783","article-title":"Combination of primary hemostatic disorders and atrial fibrillation increases bleeding events following transcatheter aortic valve replacement","volume":"7","author":"Matsushita","year":"2023","journal-title":"TH Open"},{"issue":"23","key":"10.1016\/j.jcin.2025.08.011_bib18","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jcin.2025.08.011_bib19","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1055\/s-0038-1639352","article-title":"CT-ADP point-of-care assay predicts 30-day paravalvular aortic regurgitation and bleeding events following transcatheter aortic valve replacement","volume":"118","author":"Kibler","year":"2018","journal-title":"Thromb Haemost"},{"issue":"9","key":"10.1016\/j.jcin.2025.08.011_bib20","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1055\/s-0040-1713424","article-title":"Paradoxical increase of stroke in patients with defect of high molecular weight multimers of the von Willebrand factors following transcatheter aortic valve replacement","volume":"120","author":"Matsushita","year":"2020","journal-title":"Thromb Haemost"},{"issue":"36","key":"10.1016\/j.jcin.2025.08.011_bib21","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jcin.2025.08.011_bib22","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.jcin.2025.08.011_bib23","first-page":"58","article-title":"von Willebrand factor abnormalities in aortic valve stenosis: Pathophysiology and impact on bleeding","volume":"106","author":"Casonato","year":"2011","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.jcin.2025.08.011_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa022831","article-title":"Acquired von Willebrand syndrome in aortic stenosis","volume":"349","author":"Vincentelli","year":"2003","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jcin.2025.08.011_bib25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/jamacardio.2016.0075","article-title":"Von Willebrand factor abnormalities and Heyde syndrome in dysfunctional heart valve prostheses","volume":"1","author":"Blackshear","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"6","key":"10.1016\/j.jcin.2025.08.011_bib26","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/cvr\/cvac192","article-title":"Aortic stenosis and the haemostatic system","volume":"119","author":"Trimaille","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1016\/j.jcin.2025.08.011_bib27","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/CIRCRESAHA.116.305046","article-title":"Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions","volume":"116","author":"Van Belle","year":"2015","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.jcin.2025.08.011_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101242","article-title":"Von Willebrand factor activity association with outcomes after transcatheter edge-to-edge mitral valve repair","volume":"3","author":"Hadjadj","year":"2024","journal-title":"JACC Adv"},{"issue":"5","key":"10.1016\/j.jcin.2025.08.011_bib29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcin.2015.02.008","article-title":"Treatment of acquired von Willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement","volume":"8","author":"Spangenberg","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.jcin.2025.08.011_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.011848","article-title":"Reduction of gastrointestinal bleeding in patients with Heyde syndrome undergoing transcatheter aortic valve implantation","volume":"15","author":"Goltstein","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.jcin.2025.08.011_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/jcdd11040111","article-title":"Ex vivo antiplatelet effects of oral anticoagulants","volume":"11","author":"Renda","year":"2024","journal-title":"J Cardiovasc Dev Dis"},{"issue":"24","key":"10.1016\/j.jcin.2025.08.011_bib32","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.jcin.2022.10.018","article-title":"Oral anticoagulant dose adjustment after TAVR: the role of closure time with adenosine diphosphate","volume":"15","author":"Matsushita","year":"2022","journal-title":"JACC Cardiovasc Interv"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825021909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825021909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:57:02Z","timestamp":1791860222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879825021909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":32,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1936879825021909"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2025.08.011","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refining Bleeding Risk Stratification After TAVR","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2025.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}